Qynapse

About:

Qynapse leverages neuroimaging & AI to advance the accuracy and reliability of Central Nervous System diseases screening and monitoring.

Website: http://www.qynapse.com/

Twitter/X: qynapse

Top Investors: AGORANOV

Description:

Qynapse is on a mission to advance the accuracy and reliability of Central Nervous System (CNS) diseases screening and monitoring in both clinical routine settings and in clinical trial applications. We combine MRI scans and AI to produce rapid, actionable insights.The company is headquartered in France, in the United States and in Canada.

Total Funding Amount:

$6.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2015-01-01

Contact Email:

contact(AT)qynapse.com

Founders:

Olivier Courrèges

Number of Employees:

11-50

Last Funding Date:

2021-06-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai